516-517 / 1778
Patient characteristics
Overall & Failure Free Survival
De Boer et al. Lancet Oncol 2018
5 yr OS: 82% (CTRT) versus 77% (RT)
5 yr FFS: 76% (CTRT) versus 69% (RT)
No. at risk (censored)
RT
CTRT
|
|
516-517 / 1778
Patient characteristics
Overall & Failure Free Survival
De Boer et al. Lancet Oncol 2018
5 yr OS: 82% (CTRT) versus 77% (RT)
5 yr FFS: 76% (CTRT) versus 69% (RT)
No. at risk (censored)
RT
CTRT